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We describe the incidental detection of  patients infiltrates due to COVID-19 in lung basal sections in patients undergoing abdominal 
computed tomography (CT) with flank pain attending the urology outpatient clinic during the current pandemic.
Methods
We retrospectively analysed 276 patients admitted to the Siirt Training and Research Hospital Urology outpatients clinic between 15 
March 2020 and 9 August 2020 with a complaint of  flank pain and undergoing non-contrast abdominal CT. A total of  10 patients 
with COVID-19 compatible findings in CT were defined as the study group. A control group was formed from 10 patients with only 
urological pathologies (kidney stones, ureteral stones, and hydronephrosis) without a COVID-19 compatible appearance on CT.
Results
Ten (3.6 %) patients were identified with COVID-19 and pneumonic infiltrations in the basal regions of  the lungs; diagnosis was 
made by cross-sectional abdominal CT. The visual analog scale (VAS) score of  flank pain was significantly higher in the control group 
(p<0.001); these subjects had urological pathology and no evidence of  COVID-19 in the basal regions of  the lungs on abdominal 
CT. There were no signs of  COVID-19 disease detected during the admissions procedure in the urology outpatient clinic, including 
fever, cough, and shortness of  breath.
Conclusion 
During the COVID-19 pandemic, it is important to consider a diagnosis of  COVID_19 in patients reporting non-severe flank pain if  
no urological pathology is evident on abdominal CT scans. 
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Introduction
In December 2019, Wuhan, the capital of  China’s Hubei 
region, began to experience cases of  pneumonia that did not 
respond to standard treatments. The cause of  this infection 
was subsequently identified as a new coronavirus referred 
to as severe acute respiratory syndrome coronavirus (SARS-
CoV-2)1. SARS-CoV-2 is a β-coronavirus and is enveloped by 
a non-segmented positive-sense RNA virus2. This infection 
subsequently spread rapidly across the world. On 11 March 
2020, the World Health Organization (WHO) declared a 
pandemic3. As of  9 August 2020, the number of  confirmed 
cases in Turkey was 240,804 and the number of  recovered 
cases was 223,759. The number of  patients who died during 
this time due to the virus was 5844. Coronavirus disease 
2019 (COVID-19) is highly contagious and can progress 
rapidly to acute respiratory distress syndrome (ARDS), 
often leading to death4,5. Older men with comorbidities are 
more likely to suffer from respiratory failure as a result of  
COVID-19 infection, and some patients have progressed 
rapidly to multi-organ dysfunction6. The Centers for Disease 
Control and Prevention (CDC) recommends that after two 
negative respiratory tests separated by ≥ 24 h, patients can 
be dismissed from having a transmissibility infection risk for 
COVID-19. Most patients have normal or reduced white 
blood cell counts in their laboratory examinations, and 
lymphocytopenia7,8.
Computed tomography (CT) findings are critical in the 
diagnosis of  COVID-19. However, the imaging findings of  
COVID-19 are not specific and vary widely. Nevertheless, the 
most common findings are round pulmonary parenchymal 
ground-glass opacities without lung cavitation, separate 
pulmonary nodules, or pleural effusion9. Other less common 
imaging features include linear densities, a pavement pattern, 
bronchial wall thickening, and a reverse halo sign10.
In this study, we describe a cohort of  patients admitted 
to our urology outpatient clinic during the pandemic and 
complaining of  flank pain. These patients were incidentally 
observed to have ground-glass densities that were compatible 
with COVID-19 in basal lung sections on abdominal CT 
images.
Patients and methods
The Institutional Ethical Board approved this study which 
was carried out in Siirt University (Approval Number 
2020/08.01). In our routine practice, patients with a family 
or personal history of  urolithiasis, and have findings that 
support the presence of  a stone in laboratory examinations 
are generally offered non-contrast abdomen CT. Data 
relating to patients with flank pain are routinely recorded in 
a Microsoft Excel program in our hospital’s urology clinic. 
The severity of  this flank pain was scored and recorded 
on a scale of  1–10 using the visual analog scale (VAS) pain 
scoring system (Figure 1). A total of  276 patients were 
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admitted to the Siirt Training and Research Hospital Urology 
outpatient clinic between 15 March 2020 and 9 August 2020 
complaining of  flank pain. These patients underwent non-
contrast abdominal CT. We analysed this data retrospectively 
accompanied by a radiologist with 5 years of  post-fellowship 
experience. Abdominal CT images were acquired for all 
patients and analysed using the Siso-Pacs image archiving 
and communication system (Sisoft Healthcare Information 
Systems, Ankara, Turkey). Abdominal CT images were 
reexamined in the lung parenchyma window, and patients 
showing ground-glass density that was compatible with 
COVID-19 findings in the basal regions of  the lungs were 
included in the study. Ten patients with CT findings that 
were consistent with COVID-19 were classified as the study 
group. A control group was formed from 10 patients who 
only showed urological pathologies (kidney stones, ureteral 
stones, hydronephrosis.) without a COVID-19 compatible 
CT appearance. The two groups were compared statistically 
according to the selected parameters. Patients with respiratory 
symptoms at admission, and only those with ultrasound 
(US) imaging, were excluded. Also, patients with a negative 
polymerase chain reaction (PCR) test for COVID-19 were 
excluded.
Statistical analysis
SPSS Statistical software version 25.0 (IBM, Armonk, NY, 
USA) was used for all statistical analyses. The Shapiro–
Wilk test was used to test the numerical variables for 
normality. Continuous variables were specified as means and 
standard deviations, or medians and interquartile ranges, as 
appropriate. The chi-square (χ2) test and Fisher’s exact test 
were applied to categorical variables. Student’s t-test and the 
Mann‐Whitney U test were used for continuous variables. A 
P-value <0.05 was defined as statistical significance.
Results
Ten (3.6 %) patients with COVID-19 infection were shown 
to have pneumonic infiltrations in the basal lung regions on 
cross-sectional abdominal CT scans. Three of  these patients 
had unilateral infiltrations (Figure 2); the remaining seven 
patients had bilateral infiltration (Figure 3). The male to 
female ratio was 6:4 and the mean age was 52.4±21.6 years. 
Four patients reported pain in their right flank, four patients 
reported pain in their left flank, and two patients reported 
bilateral flank pain. In one patient, two 5-mm-sized stones 
were detected in the right kidney and a 5-mm-sized stone was 
detected in the middle part of  the right ureter. One patient 
had a bilateral grade one hydronephrosis; during retrospective 
analysis, it was observed that the hydronephrosis was a 
chronic condition. In the other eight patients, no urological 
pathologies were observed upon abdominal CT. A 16-year-
old patient reported pain in the left flank that was reflected 
in the left testicle. This patient showed no abnormalities 
on abdominal CT scans. Scrotal Doppler ultrasonography, 
however, detected left epididymo-orchitis.
During admissions to the urology outpatient clinic, there 
were no signs of  COVID-19, such as fever, cough, and 
shortness of  breath. In our study group, the PCR test was 
positive in all 10 patients with COVID-19 findings in the 
basal lung regions on abdominal CT. The median length 
of  time taken for these patients to attend the COVID-19 
outpatient clinic with another symptom after leaving the 
urology outpatient clinic was 2.4 (range: 1–5) days. The 
median VAS score of  patients with COVID-19 findings on 
abdominal CT scans was 4 points. The median VAS score of  
patients with urological pathology but without COVID-19 
findings was 8 points. 
The VAS score was significantly higher (P<0.001) in the 
control group with urological pathology and no COVID-19 
findings in the basal lung regions on abdominal CT (Table 1).
Figure 1. Visual analog scale (VAS) for scoring pain
Figure 2. Unilateral basal pneumatic infiltrations. (A) 
A 54-year-old male was admitted with pain in the right 
flank. An abdominal non-contrast CT showed ground-
glass density compatible with COVID-19 in the right lung 
base. (B) A 16-year-old male who presented with pain in 
the left flank and the left testicle. Axial abdominal CT 
demonstrated nodular ground-glass density compatible 
with COVID-19 in the left lung base section.
Figure 3. Bilateral basal lung pneumatic involvements. (A) 
A 47-year-old male presented with pain in the left flank. A 
basal thoracic section of abdominal CT was carried out. In 
bilateral lung basal sections, there were consolidation areas 
with ground-glass density compatible with COVID-19. 
Subpleural involvement on the left side. (B) A 68-year-
old female with pain in the right flank. Axial abdominal 
CT showed peribronchial thickening in the bilateral lung 
basal sections and consolidations in the subpleural areas as 
peribronchial ground-glass regions.
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Discussion
COVID-19 is spreading rapidly worldwide, although there is 
still no effective drug treatment, studies on the vaccine are 
ongoing.. However, the transmission rate of  this infection 
can be reduced if  the population take specific precautions. 
Therefore, it is essential to detect patients with COVID-19 
early in order to prevent the spread of  infection11,12. Medical 
treatments (antivirals, antibiotics, corticosteroids, and 
hydroxychloroquine) have been administered as supportive 
therapies. A standard treatment protocol for use across the 
world has yet to be developed. Many treatment options have 
been attempted in China and other countries, and their effects 
have been published. For example, a recent study identified 
four small molecular drugs (prulifloxacin, nelfinavir, 
bictegravir, and tenofovir) which exhibit high binding 
capacities with the main protease of  SARS-CoV-213. It has 
also been shown that agents such as remdesivir, chloroquine, 
and baricitinib, can be used to treat COVID-1914,15. Although 
the most common symptom of  COVID-19 infection is 
fever, cough and shortness of  breath are also considered 
to be the other most common symptoms16,17. Uncommon 
symptoms such as abdominal pain, diarrhoea, and olfactory 
disorders, have also been reported in the literature as first-
line symptoms18–20. However, flank pain has not yet been 
identified as a first-line symptom. According to our literature 
review, there has been no patient-based research investigating 
the abdominal CT images of  patients presenting with flank 
pain with regards to COVID-19.
The sensitivity of  US in detecting urinary stones varies from 
3% to 98% according to the existing literatüre21,22. US can be 
challenging in obese patients and generally offers limited or 
poor visualisation of  the mid ureter. Furthermore, US has 
only limited ability to depict renal or ureteral calculi, which 
are smaller than 5 mm. However, detecting calculi smaller 
than 5 mm is of  questionable clinical significance, as such 
patients are unlikely to require urological intervention23. 
Many studies have shown that non-contrast abdominal CT 
is unlikely to miss stones that require intervention compared 
to US24,25. Recent data suggest that less than 7% of  patients 
diagnosed with kidney stones were scanned by US; rather, 
the use of  CT is increasing26. The American College of  
Radiology Appropriateness Criteria states that a low-dose 
non-enhanced CT of  the abdomen and pelvis is the imaging 
examination of  choice for evaluating patients with suspected 
urolithiasis (with a sensitivity of  97% and a specificity of  
95%)27. Non-contrast abdominal CT can sometimes be 
the first imaging method used in patients with severe renal 
colic28.
The prevalence of  stone disease is very high in our region. 
For this reason, in our clinic, patients with a history of  
urolithiasis in the themselves or in their family, and who 
have the findings to support the presence of  a stone in their 
laboratory examinations, are generally scanned by abdominal 
CT to detect suspected kidney and uretal stones that are not 
evident on US.
A recent publication describing COVID-19 and CT imaging 
reported that the sensitivity of  thorax CT (98%) in the early 
diagnosis of  COVID-19 was higher than that of  the reverse 
transcription (RT)-PCR test (71%)29. This information 
increases the importance of  thorax CT in the diagnosis of  
this infection. During the pandemic period in our country, 
all physicians, irrespective of  their specialty, were required 
to take care of  COVID-19 patients. Our experience with the 
thorax CT imaging method, which we usually do not use as a 
specialist urology tool, has increased during this period. We 
had the opportunity to use and evaluate many thorax CTs. In 
this way, we learned to assess the basal lungs on abdominal 
CT scans, which we acquired for urological reasons, in the 
lung parenchyma window. For COVID-19 infection, the 
most common findings of  thorax CTs are round pulmonary 
parenchymal ground-glass opacities.
Studies show that 5.74% of  COVID-19 patients have viral 
RNA in their urine samples. Viral shedding in stools can 
take up to 6 weeks, but there is no definitive data relating to 
the duration of  viral shedding in urine samples. Therefore, 
precautions are needed when we perform transurethral or 
transrectal procedures30. In our present study, it was not 
possible to test for viral RNA in urine samples as the patients 
were evaluated retrospectively.
The first diagnosis that comes to mind in a patient admitted to 
the urology outpatient clinic with flank pain is stone disease. 
However, there may be flank pain associated with diseases of  
















































































4 (0.5) 8 (2) 6 (4) <0.001
Table 1. Patient characteristics and clinical features
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diseases of  the chest. Abdominal and back pain have long 
been described as a symptom of  pneumonia in adults and 
children secondary to pleural irritation31,32. Parambil et al. 
reported right flank pain as the first presentation complaint 
related to COVID-19 in a 73-year-old patient33. When the 
patients who attended the urology outpatient clinic during 
the pandemic period were retrospectively screened, we 
found that 10 patients (3.6 %) presented with flank pain and 
COVID-19, with abdominal CT scans that were compatible 
with pneumonic infiltrations in the basal regions of  the 
lungs. In some patients, flank pain may occur due to parietal 
pleural irritation caused by pulmonary inflammation during 
COVID-19 infection. The parietal pleura is innervated by 
the intercostal nerves, which also innervate the rib cage in 
a dermatomal fashion. Irritation of  the pleural branches of  
the intercostal nerves may thus result in hyperaesthesia of  
the cutaneous branches which innervate the flank area34. As 
the COVID-19 pandemic continues, it should be kept in 
mind that if  the pain score according to the VAS pain scoring 
system is not very high in patients presenting with flank 
pain, and there is no urological pathology in the abdominal 
CT, there is a possibility that this pain may be a COVID-19 
symptom. Moreover, radiologists should not overlook 
COVID-19 when evaluating images of  abdominal CTs taken 
in standard clinics other than the pandemic outpatient clinic. 
Unfortunately, there is no more effective option to contend 
with the COVID-19 pandemic than to reduce contagion.
Our study was limited by the fact that it was performed 
retrospectively in a single centre and with a limited number 
of  patients. Multicentre and more comprehensive studies are 
now needed to verify our findings.
Conclusion
COVID-19 patients may visit many departments and spread 
the infection with extrapulmonary findings. This situation 
may pose a risk to healthcare professionals and other patients. 
If  patients present with non-severe flank pain during the 
pandemic period, and if  no urological pathology is observed 
on abdominal CT, then we should consider a differential 
diagnosis of  COVID-19.
Before radiologists report their findings, clinicians should 
be knowledgeable enough to evaluate the basal regions of  
the lungs entering the cross-sectional CT area of  abdominal 
CT scans for COVID-19 infection. In this way, clinicians 
can protect themselves and other healthcare workers from 
transmission during clinical examinations. In this way, 
patients can be diagnosed earlier before severe COVID-19 
symptoms begin.
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